Ecg Paediatric
Carmine Osterland
Following the resolution at the 69th World Health Assembly on promoting innovation and access to quality, safe, efficacious and affordable medicines for children, GAP-f was conceived to build on and formalize the model developed within the HIV community to provide a sustainable mechanism that ensures that safer, more effective, and more durable paediatric formulations are developed and made available to children against an accelerated timeline.
At GAP-f, Children are at the top of our agenda. While there have been significant achievements in child health with six million fewer children under the age of five years dying in 2016 than in 1990, urgent action is needed to achieve the UN Sustainable Development Goals (SDG), particularly SDG 3, which aims to ensure healthy lives and promote wellbeing for all people at all ages and the related target to achieve Universal Health Coverage by 2030.
The European Association of Urology (EAU) Paediatric Urology Guidelines Panel has prepared these Guidelines with the aim of increasing the quality of care for children with urological conditions. This Guideline document is limited to a number of common clinical pathologies in paediatric urological practice, as covering the entire field of paediatric urology in a single guideline document is unattainable.
The majority of urological clinical problems in children are specialised and in many ways differ to those in adults. This publication intends to outline a practical and preliminary approach to paediatric urological conditions. Complex and rare conditions that require special care with experienced doctors should be referred to designated centres where paediatric urology practice has been fully established and a multidisciplinary team is available.
Over time, paediatric urology has developed and matured, establishing its diverse body of knowledge and expertise and may now be ready to distinguish itself from its parent specialties. Thus, paediatric urology has recently emerged in many European countries as a distinct subspecialty of both urology and paediatric surgery and presents a unique challenge in the sense that it covers a large area with many different schools of thought and a huge diversity in management.
Knowledge gained by increasing experience, new technological advances and non-invasive diagnostic screening modalities has had a profound influence on treatment modalities in paediatric urology, a trend that is likely to continue in the years to come.
It must be emphasised that clinical guidelines present the best evidence available to the experts but following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients, but rather help to focus decisions - also taking personal values and preferences/individual circumstances of children and their caregivers into account. Guidelines are not mandates and do not purport to be a legal standard of care.
The EAU Paediatric Urology Guidelines Panel consists of an international group of clinicians with particular expertise in this area. All experts involved in the production of this document have submitted potential conflict of interest statements, which can be viewed on the EAU Website: -urology/panel
A quick reference document (Pocket guidelines) is available this is an abridged versions which may require consultation together with the full text version. A number of translated versions, alongside several scientific publications are also available [1-7]. All documents can be viewed through the EAU website: -urology.
A paediatrician is a child's physician who provides not only medical care for children who are acutely or chronically ill but also preventive health services for healthy children. A paediatrician manages physical, mental, and emotional well-being of the children under their care at every stage of development, in both sickness and health.
The aims of the study of paediatrics is to reduce infant and child rate of deaths, control the spread of infectious disease, promote healthy lifestyles for a long disease-free life and help ease the problems of children and adolescents with chronic conditions.
Paediatrics is concerned not only about immediate management of the ill child but also long term effects on quality of life, disability and survival. Paediatricians are involved with the prevention, early detection, and management of problems including:-
Paediatrics is a collaborative specialty. Paediatricians need to work closely with other medical specialists and healthcare professionals and subspecialists of paediatrics to help children with problems.
Paediatrics is different from adult medicine in more ways than one. The smaller body of an infant or neonate or a child is substantially different physiologically from that of an adult. So treating children is not like treating a miniature adult.
Congenital defects, genetic variance, and developmental issues are of greater concern to pediatricians than physicians treating adults. In addition, there are several legal issues in paediatrics. Children are minors and, in most jurisdictions, cannot make decisions for themselves. The issues of guardianship, privacy, legal responsibility and informed consent should be considered in every pediatric procedure.
A paediatrician is a graduate from a medical school first. He or she being a primary care paediatrician then completes three years of education in an accredited pediatric residency program. They learn about caring for infant, child, adolescent, and young adults during this period.
Following the pediatric residency, the pediatrician is eligible for board certification by the American Board of Paediatrics with successful completion of a comprehensive written examination. Recertification is required every seven years.
Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.
While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.
Paediatrics & Child Health (PCH) is the official journal of the Canadian Paediatric Society, and the only peer-reviewed paediatric journal in Canada. Its mission is to advocate for the health and well-being of all Canadian children and youth and to educate child and youth health professionals across the country.
We celebrate women around the world who have made significant contributions to paediatric oncology, led the strife for the cure and care of childhood cancer patients and their families, and mentored young professionals.
We invite you to renew your SIOP membership for calendar year 2024. Please log in to SIOP CONNECT to join or renew. For group membership or to purchase more than 2 years of membership, please email membe...@siop-online.org .
The information given here supplements that given in Chapters 2 and 3. Users of these guidelines should read Chapters 2 and 3 before reading the information given below. This chapter covers background information (Section 6.1), practical guidance (Section 6.2) and illustrations (Section 6.3) relevant to paediatric and neonatal blood sampling.
This chapter discusses aspects specific to paediatric and neonatal blood sampling (60, 61). Anyone taking blood from children and neonates must be well trained and practiced in venepuncture techniques. A uniform sampling technique is important to reduce pain and psychological trauma.
Patient immobilization is crucial to the safety of the paediatric and neonatal patient undergoing phlebotomy, and to the success of the procedure. A helper is essential for properly immobilizing the patient for venepuncture or finger-prick, as described in Section 6.2.
Ask whether the parent would like to help by holding the child. If the parent wishes to help, provide full instructions on how and where to hold the child; if the parent prefers not to help, ask for assistance from another phlebotomist.
The ESPE and the entire paediatric endocrinology community is saddened by the devastating situation in Turkey and Syria following the recent earthquake. We stand by our colleagues who have been affected and wish them strength, courage and hope in these difficult times. ESPE will actively support the Turkish Society of Paediatric Endocrinology and will do so by way of aid to the region
The European Society for Paediatric Endocrinology (ESPE) is an international society based in Europe that promotes the highest levels of clinical care for infants, children and adolescents with endocrine problems throughout the world, including in less advantaged areas.
Welcome to the homepage of the Paediatric Radiation Oncology Society, PROS. We aim to bring together all radiation oncologists and allied professionals involved in paediatric oncology. This website provides a forum for dialogue between professionals, information on educational opportunities, and a platform for teaching resources.
This website uses cookies to give you the best experience. By continuing to use this website you are consenting to cookies being used. You can delete and block cookies from within your browsers settings. For more information please refer to our privacy and cookie policy page.
Whether you are looking to learn more about paediatric musculoskeletal problems, or are involved in the care of children, then PMM and PMM-Nursing will help you change your clinical practice for the better. PMM is free and open to all !
The European Commission published a Roadmap on the evaluation of the orphan and paediatric legislation (medicines for special populations). This Roadmap was a first step in the evaluation process and outlined the purpose, content and scope of the evaluation. Stakeholders were invited to submit comments on the Roadmap until 8 January 2018. To view the feedback received, please click here.
c80f0f1006